The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project
Authors:
- Onofre CombarrosOCOnofre Combarros
- Donald R WardenDWDonald R Warden
- Naomi HammondNHNaomi Hammond
- Mario Cortina-BorjaMCMario Cortina-Borja
- Olivia BelbinOBOlivia Belbin
- Michael G LehmannMLMichael G Lehmann
- Gordon K WilcockGWGordon K Wilcock
- Kristelle BrownKBKristelle Brown
- Patrick G KehoePatrick G Kehoe
- Rachel BarberRBRachel Barber
- Eliecer CotoECEliecer Coto
- Victoria AlvarezVAVictoria Alvarez
Open Access
- 11 November 2010
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11 (1) , 1-10
Abstract
The loss of noradrenergic neurones of the locus coeruleus is a major feature of Alzheimer's disease (AD). Dopamine β-hydroxylase (DBH) catalyses the conversion of dopamine to noradrenaline. Interactions have been reported between the low-activity -1021T allele (rs1611115) of DBH and polymorphisms of the pro-inflammatory cytokine genes, IL1A and IL6, contributing to the risk of AD. We therefore examined the associations with AD of the DBH -1021T allele and of the above interactions in the Epistasis Project, with 1757 cases of AD and 6294 elderly controls. We genotyped eight single nucleotide polymorphisms (SNPs) in the three genes, DBH, IL1A and IL6. We used logistic regression models and synergy factor analysis to examine potential interactions and associations with AD. We found that the presence of the -1021T allele was associated with AD: odds ratio = 1.2 (95% confidence interval: 1.06-1.4, p = 0.005). This association was nearly restricted to men < 75 years old: odds ratio = 2.2 (1.4-3.3, 0.0004). We also found an interaction between the presence of DBH -1021T and the -889TT genotype (rs1800587) of IL1A: synergy factor = 1.9 (1.2-3.1, 0.005). All these results were consistent between North Europe and North Spain. Extensive, previous evidence (reviewed here) indicates an important role for noradrenaline in the control of inflammation in the brain. Thus, the -1021T allele with presumed low activity may be associated with misregulation of inflammation, which could contribute to the onset of AD. We suggest that such misregulation is the predominant mechanism of the association we report here.Keywords
This publication has 92 references indexed in Scilit:
- Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicityJournal of Neurochemistry, 2010
- Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrineProceedings of the National Academy of Sciences, 2010
- Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microgliaJournal of Neuroinflammation, 2010
- Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressureJournal Of Hypertension, 2010
- Genomewide Association Studies of StrokeNew England Journal of Medicine, 2009
- Noradrenergic Depression of Neuronal Excitability in the Entorhinal Cortex via Activation of TREK-2 K+ ChannelsJournal of Biological Chemistry, 2009
- The synergy factor: a statistic to measure interactions in complex diseasesBMC Research Notes, 2009
- Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's diseaseJournal of Neuroinflammation, 2009
- C/T conversion alters interleukin-1A promoter function in a human astrocyte cell lineLife Sciences, 2007
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007